Effect of Ghrelin on mortality and cardiovascular outcomes in experimental rat and mice models of heart failure: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Khatib, Mahalaqua Nazli ^a   Shankar, Anuraj ^b   Kirubakaran, Richard ^c   Agho, Kingsley ^d   Simkhada, Padam ^e   Gaidhane, Shilpa ^a   Saxena, Deepak ^f   Unnikrishnan, B ^g   Gode, Dilip ^a   Gaidhane, Abhay ^a   Zahiruddin, Syed Quazi ^a  

^a DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^f PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^g MANIPAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; PLACEBO; CARDIOTONIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; DRUG EFFICACY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HEART PROTECTION; HEART RATE; HUMAN; MEAN ARTERIAL PRESSURE; META ANALYSIS; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; RAT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALIA; MUS; RATTUS; SCOPUS;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; GHRELIN; HEART FAILURE; HEART RATE; MICE; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT;

EID: 84939551585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126697     Document Type: Article

References (67)

1. Robertson J, McElduff P, Pearson SA, Henry DA, Inder KJ, Attia JR. The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Serv Res. 2012; 12:103. doi: 10.1186/1472-6963-12-103 PMID: 22533631
2. Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012 Jul 24; 126(4):501-6. doi: 10.1161/CIRCULATIONAHA.112.125435 PMID: 22825412
3. Butler J, Kalogeropoulos A. Worsening heart failure hospitalization epidemic we do not know how to prevent and we do not know how to treat! J Am Coll Cardiol. 2008 Aug 5; 52(6):435-7. doi: 10.1016/j.jacc.2008.04.037 PMID: 18672163
4. Stewart S, MacIntyre K, Capewell S, McMurray JJ. Heart failure and the aging population: an increasing burden in the 21st century? Heart. 2003 Jan; 89(1):49-53. PMID: 12482791
5. Tully PJ. Quality-of-Life measures for cardiac surgery practice and research: a review and primer. J Extra Corpor Technol. 2013 Mar; 45(1):8-15. PMID: 23691778
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999 Dec 9; 402(6762):656-60. PMID: 10604470
7. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004 Jan; 145(1):234-42. PMID: 14551228
8. Mao Y, Tokudome T, Kishimoto I. Ghrelin As a Treatment for Cardiovascular Diseases. Hypertension. 2014 Jun 23.
9. Tokudome T, Kishimoto I, Miyazato M, Kangawa K. Ghrelin and the cardiovascular system. Front Horm Res. 2014; 43:125-33. doi: 10.1159/000360593 PMID: 24943303
10. Miki K, Maekura R, Nagaya N, Kitada S, Miki M, Yoshimura K, et al. Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment. BMC Pulm Med. 2013; 13:37. doi: 10.1186/1471-2466-13-37 PMID: 23758800
11. Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One. 2012; 7(5):e35708. doi: 10.1371/journal.pone.0035708 PMID: 22563468
12. Strasser F. Clinical application of ghrelin. Curr Pharm Des. 2012; 18(31):4800-12. PMID: 22632860
13. Ohta K, Laborde NJ, Kajiya M, Shin J, Zhu T, Thondukolam AK, et al. Expression and possible immune-regulatory function of ghrelin in oral epithelium. J Dent Res. 2011 Nov; 90(11):1286-92. doi: 10.1177/0022034511420431 PMID: 21865591
14. Nazli Khatib SG, Gaidhane AM, Simkhada P, Gode D, Zahiruddin QS. Ghrelin: Ghrelin as a Regulatory Peptide in Growth Hormone Secretion. JCDR. 2014; 8(8):MC13-MC7. doi: 10.7860/JCDR/2014/9863.4767 PMID: 25302229
15. Goldstone AP, Prechtl CG, Scholtz S, Miras AD, Chhina N, Durighel G, et al. Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food. Am J Clin Nutr. 2014 Apr 23; 99(6):1319-30. doi: 10.3945/ajcn.113.075291 PMID: 24760977
16. Nazli MK, Gaidhane S, Gaidhane A, Zahiruddin QS. Ghrelin for regulating appetite and energy balance: A systematic review. National Journal of Physiology, Pharmacy and Pharmacology. 2014; 4(3):101-5.
17. Khatib MN ZQSG D, Simkhada P, Agho K, Gaidhane S, Saxena D, Unnikrishnan B, et al. Somatotropic and cardio-protective effects of ghrelin in experimental models of heart failure: A systematic review. Ann Trop Med Public Health. 2014; 7:30-42.
18. Nagaya N, Kangawa K. Therapeutic potential of ghrelin in the treatment of heart failure. Drugs. 2006; 66(4):439-48. PMID: 16597162
19. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004 Dec 14; 110(24):3674-9. PMID: 15569841
20. Yang C, Liu Z, Liu K, Yang P. Mechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression. PLoS One. 2014; 9(1):e85785. doi: 10.1371/journal.pone.0085785 PMID: 24465706
21. Khatib MNPS, Gode D. Cardioprotective Effects of Ghrelin in Heart Failure: From Gut to Heart. Heart Views. 2014; 15(3):74-6. doi: 10.4103/1995-705X.144792 PMID: 25538820
22. Isgaard J. Ghrelin and the cardiovascular system. Endocr Dev. 2013; 25:83-90. doi: 10.1159/000346056 PMID: 23652394
23. Khatib MN S P, Gode D Cardioprotective effects of ghrelin in heart failure: From gut to heart. Heart Views. 2014; 15:74-6. doi: 10.4103/1995-705X.144792 PMID: 25538820
24. Shimada T, Furuta H, Doi A, Ariyasu H, Kawashima H, Wakasaki H, et al. Des-acyl ghrelin protects microvascular endothelial cells from oxidative stress-induced apoptosis through sirtuin 1 signaling pathway. Metabolism. 2014 Apr; 63(4):469-74. doi: 10.1016/j.metabol.2013.12.011 PMID: 24486147
25. Shu ZW, Yu M, Chen XJ, Tan XR. Ghrelin could be a candidate for the prevention of in-stent restenosis. Cardiovasc Drugs Ther. 2013 Aug; 27(4):309-14. doi: 10.1007/s10557-013-6453-1 PMID: 23512274
26. Wang L, Chen Q, Li G, Ke D. Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells. Peptides. 2012 Jan; 33(1):92-100. doi: 10.1016/j.peptides.2011.11.001 PMID: 22100225
27. Wang L, Chen QW, Li GQ, Ke DZ. Ghrelin stimulates in vitro angiogenic capacity of rat cardiac microvascular endothelial cells. Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jan; 40(1):50-6. PMID: 22490634
28. Zaniolo K, Sapieha P, Shao Z, Stahl A, Zhu T, Tremblay S, et al. Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a. Invest Ophthalmol Vis Sci. 2011 Jul; 52(8):5376-86. doi: 10.1167/iovs.10-7152 PMID: 21642627
29. Wang X, Wang XL, Chen HL, Wu D, Chen JX, Wang XX, et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Biochem Pharmacol. 2014 Apr 1; 88(3):334-50. doi: 10.1016/j.bcp.2014.01.040 PMID: 24522112
30. Mao Y, Tokudome T, Kishimoto I, Otani K, Hosoda H, Nagai C, et al. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction. Endocrinology. 2013 Oct; 154(10):3847-54. doi: 10.1210/en.2013-1291 PMID: 23861368
31. Mao Y, Tokudome T, Kishimoto I, Otani K, Miyazato M, Kangawa K. One dose of oral hexarelin protects chronic cardiac function after myocardial infarction. Peptides. 2014 Jun; 56:156-62. doi: 10.1016/j.peptides.2014.04.004 PMID: 24747279
32. Yuan MJ, He H, Hu HY, Li Q, Hong J, Huang CX. Myocardial angiogenesis after chronic ghrelin treatment in a rat myocardial infarction model. Regul Pept. 2012 Nov 10; 179(1-3):39-42. doi: 10.1016/j.regpep.2012.08.016 PMID: 22989472
33. Rizzo M, Rizvi AA, Sudar E, Soskic S, Obradovic M, Montalto G, et al. A review of the cardiovascular and anti-atherogenic effects of ghrelin. Curr Pharm Des. 2013; 19(27):4953-63. PMID: 23278489
34. Kemp BA, Howell NL, Gildea JJ, Padia SH. Intrarenal ghrelin receptor antagonism prevents high-fat diet-induced hypertension in male rats. Endocrinology. 2014 Jul; 155(7):2658-66. doi: 10.1210/en.2013-2177 PMID: 24797629
35. Yano Y, Nakazato M, Toshinai K, Inokuchi T, Matsuda S, Hidaka T, et al. Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. Am J Hypertens. 2014 May; 27(5):727-33. doi: 10.1093/ajh/hpt232 PMID: 24363280
36. Zhang G, Yin X, Qi Y, Pendyala L, Chen J, Hou D, et al. Ghrelin and cardiovascular diseases. Curr Cardiol Rev. 2010 Feb; 6(1):62-70. doi: 10.2174/157340310790231662 PMID: 21286280
37. Ma Y, Zhang L, Edwards JN, Launikonis BS, Chen C. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium. PLoS One. 2012; 7(4):e35265. doi: 10.1371/journal.pone.0035265 PMID: 22493744
38. Higgins JSG. Cochrane Handbook for Systematic Reviews of Interventions.: The Cochrane Collaboration; 2011.
39. Moher D LA, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. 2009.
40. Van Luijk J, Bakker B, Rovers MM, Ritskes-Hoitinga M, de Vries RB, Leenaars M. Systematic reviews of animal studies; missing link in translational research? PLoS One. 2014; 9(3):e89981. doi: 10.1371/journal.pone.0089981 PMID: 24670965
41. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre TCC, 2014.
42. Schünemann HJ OA, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. In: Higgins JPT, Green S, editor. Chapter 12: Interpreting results drawing conclusions. Cochrane Handbook for Systematic Review of Intervention Version 5.0.1 ed: The Cochrane Collaboration; 2008.
43. Mao Y, Tokudome T, Otani K, Kishimoto I, Miyazato M, Kangawa K. Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice. Endocrinology. 2013 May; 154(5):1854-63. doi: 10.1210/en.2012-2132 PMID: 23515286
44. Mao Y, Tokudome T, Otani K, Kishimoto I, Nakanishi M, Hosoda H, et al. Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves. Endocrinology. 2012 Jul; 153(7):3426-34. doi: 10.1210/en.2012-1065 PMID: 22535766
45. Mitacchione G, Powers JC, Grifoni G, Woitek F, Lam A, Ly L, et al. The gut hormone ghrelin partially reverses energy substrate metabolic alterations in the failing heart. Circ Heart Fail. 2014 Jul; 7(4):643-51. doi: 10.1161/CIRCHEARTFAILURE.114.001167 PMID: 24855152
46. Nagaya N, Miyatake K, Uematsu M, Oya H, Shimizu W, Hosoda H, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab. 2001 Dec; 86(12):5854-9. PMID: 11739451
47. Schwenke DO, Tokudome T, Kishimoto I, Horio T, Shirai M, Cragg PA, et al. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology. 2008 Oct; 149(10):5172-6. doi: 10.1210/en.2008-0472 PMID: 18599547
48. Vestergaard ET, Andersen NH, Hansen TK, Rasmussen LM, Moller N, Sorensen KE, et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol. 2007 Nov; 293(5):H3020-6. PMID: 17873022
49. Yuan MJ, Huang H, Tang YH, Wu G, Gu YW, Chen YJ, et al. Effects of ghrelin on Cx43 regulation and electrical remodeling after myocardial infarction in rats. Peptides. 2011 Nov; 32(11):2357-61. doi: 10.1016/j.peptides.2011.10.004 PMID: 22008733
50. Akashi YJ, Palus S, Datta R, Halem H, Taylor JE, Thoene-Reineke C, et al. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol. 2009 Nov 12; 137(3):267-75. doi: 10.1016/j.ijcard.2008.06.094 PMID: 18723230
51. Zhang GG, Cai HQ, Li YH, Sui YB, Zhang JS, Chang JR, et al. Ghrelin protects heart against ERS-induced injury and apoptosis by activating AMP-activated protein kinase. Peptides. 2013 Oct; 48:156-65. doi: 10.1016/j.peptides.2013.08.015 PMID: 23994559
52. Schwenke DO, Tokudome T, Kishimoto I, Horio T, Cragg PA, Shirai M, et al. One dose of ghrelin prevents the acute and sustained increase in cardiac sympathetic tone after myocardial infarction. Endocrinology. 2012 May; 153(5):2436-43. doi: 10.1210/en.2011-2057 PMID: 22434083
53. Li L, Zhang LK, Pang YZ, Pan CS, Qi YF, Chen L, et al. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin. 2006 May; 27(5):527-35. PMID: 16626506
54. Chang L, Zhao J, Li GZ, Geng B, Pan CS, Qi YF, et al. Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacol Sin. 2004 Sep; 25(9):1131-7. PMID: 15339387
55. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 2001 Sep 18; 104(12):1430-5. PMID: 11560861
56. Freeman JN, do Carmo JM, Adi AH, da Silva AA. Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats. Peptides. 2013 Apr; 42:35-42. doi: 10.1016/j.peptides.2013.02.003 PMID: 23416021
57. Granata R, Isgaard J, Alloatti G, Ghigo E. Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp Biol Med (Maywood). 2011 May 1; 236(5):505-14. doi: 10.1258/ebm.2011.010365 PMID: 21478211
58. Nagaya N, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regul Pept. 2003 Jul 15; 114(2-3):71-7. PMID: 12832108
59. Khatib MN, Simkhada P, Gode D. Cardioprotective effects of ghrelin in heart failure: from gut to heart. Heart Views. 2014 Jul; 15(3):74-6. doi: 10.4103/1995-705X.144792 PMID: 25538820
60. Yuan MJ, Huang H, Huang CX. Potential new role of the GHSR-1a-mediated signaling pathway in cardiac remodeling after myocardial infarction (Review). Oncol Lett. 2014 Sep; 8(3):969-71. PMID: 25120643
61. Vila G, Grimm G, Resl M, Heinisch B, Einwallner E, Esterbauer H, et al. B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men. Diabetes. 2012 Oct; 61(10):2592-6. PMID: 22698919
62. Du CK, Zhan DY, Morimoto S, Akiyama T, Schwenke DO, Hosoda H, et al. Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy. Pharmacol Res Perspect. 2014 Oct; 2(5):e00064. doi: 10.1002/prp2.64 PMID: 25505608
63. Chen Y, Ji XW, Zhang AY, Lv JC, Zhang JG, Zhao CH. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure. Arch Med Res. 2014 Apr; 45(3):263-9. doi: 10.1016/j.arcmed.2014.01.004 PMID: 24508287
64. Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, et al. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides. 2009 Dec; 30(12):2286-91. doi: 10.1016/j.peptides.2009.09.004 PMID: 19747956
65. Yuan MJ, Huang H, Quan L, Tang YH, Wang X, Jiang H, et al. Expression of ghrelin and its receptor in rats after coronary artery ligation. Regul Pept. 2014 Jul 22.
66. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol. 2014; 14:43. doi: 10.1186/1471-2288-14-43 PMID: 24667063
67. Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern Lab Anim. 2010 May; 38(2):167-82. PMID: 20507187